First patients test new cancer pill in early safety trial
NCT ID NCT05318833
Summary
This was the first study in people to test a new oral drug called HRS7415 for advanced cancers. It involved 38 patients and aimed to find a safe dose and understand how the body processes the drug. The main goals were to check for side effects and see if the drug showed any early signs of helping to control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, 250021, China
Conditions
Explore the condition pages connected to this study.